PRQR
NASDAQ
$1.88
ProQR Therapeutics N.V (PRQR)
ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $8.25 (+338.83%)
Market Cap
$186M
Revenue 5Y CAGR
+121.71%
Free Cash Flow Yield
-30.75%
Beta (5Y)
1.31
Price Chart
Valuation
Market Cap$186M
P/S17.90
P/B5.70
Profitability
Total Revenue (TTM)$16M
Gross Profit (TTM)$16M
EBITDA-$50M
Operating Margin-671%
EPS-$0.50
Financial Health
Debt-to-Equity36.4%
Free Cash Flow Yield-30.75%
Growth & Risk
EPS 5Y CAGR-13.05%
Revenue 5Y CAGR+121.71%
FCF 5Y CAGR+1.86%
Beta (5Y)1.31
Sharpe Ratio-0.08